Young Leaders Caucus

Share

Young Leaders Summit participants

About the Young Leaders Caucus

The American Cancer Society Cancer Action Network Young Leaders Caucus is the ideal space for volunteers, aged 18-35, to connect and engage in cancer advocacy throughout the year. The Young Leaders Caucus fosters opportunities to connect young people to the work of ACS CAN and to others with similar interests. We work to elevate the perspectives of young people, including cancer survivors, about childhood and AYA, to inform and influence ACS CAN priorities and considerations.

Young Leaders Summit participants

Meet the steering committee

Meet the steering committee! These are the volunteer leaders of the YLC.  Learn more their role in the YLC

Young Leaders Summit participants

Photos

Check out photos from our various events here.

Young Leaders Summit participants

Newsletters

We release quarterly newsletters detailing our activity,  upcoming events, and any timely announcements.

Young Leaders Summit participants

Calendar

Find out what is happening next with ACS CAN and the YLC.

Young Leaders Summit participants sitting at a table

Resources 

Find all the resources you need to get more engaged with the YLC.

Young Leaders Summit participants working at breakout tables

Working Groups

Find a list of our working groups and their ongoing projects here.

Latest Updates

See More Updates

‘Game-Changing’ Bill Becomes Law in Iowa, Opening the Door to Precision Medicine for More Patients

May 1, 2024
Iowa

DES MOINES, Iowa – Iowa Governor Kim Reynolds signed a bill today, expanding access to  biomarker testing to more patients statewide. The American Cancer Society Cancer Action Network (ACS CAN) and its team of volunteers, including cancer survivors, patients and caregivers, applaud the governor and

ACS CAN Applauds FDA’s Rule on Laboratory Developed Test Regulation

April 29, 2024
National

Today, the Food and Drug Administration (FDA) finalized a new rule regulating laboratory developed tests (LDTs) that will harmonize oversight for diagnostic tests regardless of whether tests are performed in individual laboratories or sold as prepackaged kits.

The Administration Announces Indefinite Delay in the Finalization of the FDA Rules Prohibiting Menthol Cigarettes and all Flavors in Cigars; Prolonging Public Health Disparities 

April 26, 2024

WASHINGTON, D.C. – Today, the White House announced it is indefinitely delaying finalization of the U.S. Food and Drug Administration (FDA) proposed rule to end the sale of menthol cigarettes, without mention of eliminating all flavors in cigars, despite an overwhelming amount of evidence demonstrating menthol flavoring is a serious

White House Could Miss a Historic Opportunity to Save Lives if Rules on Menthol in Cigarettes and Flavors in Cigars are not Finalized Immediately

April 26, 2024

In 2022, the U.S. Food and Drug Administration (FDA) released proposed rules to eliminate menthol flavoring in cigarettes and all flavors in cigars. Almost two years later, the public health community is still waiting for the FDA to finalize these lifesaving rules. This inaction only benefits Big Tobacco, who continues